Brief: Acura Pharmaceuticals reports Q4 loss of $0.08/shr
29/02/2016 21:30
Feb 29 (Reuters) - Acura Pharmaceuticals Inc ACUR.O : * Announces fourth quarter and full year 2015 financial results * Q4 loss per share $0.08 * Reported a net loss of $0.9 million or $0.08 per diluted share in quarter * Qtrly net total revenues $2.7 million versus $529,000 * Source text for Eikon urn:newsml:reuters.com:*:nCCN7FyRfr * Further company coverage ACUR.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Acura Pharmaceuticals
See all newsBrief: Acura Pharmaceuticals Received A $250,000 Loan From Abuse Deterrent Pharma, LLC on October 11
Brief: Acura Pharmaceuticals Inc Receives $200,000 Loan From Abuse Deterrent Pharma
Brief: Acura Pharmaceuticals Received $250,000 Loan From AD Pharma For Operations Through End Of April 2023
Brief: Acura Pharmaceuticals, AD Pharma Amend License to LIMITx LTX-03
Insight: Novavax bosses cash out for $46 mln with COVID-19 vaccine trials still under way